These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR AND Prognosis
65 results:

  • 1. Glutamine metabolism-related genes predict the prognostic risk of acute myeloid leukemia and stratify patients by subtype analysis.
    Zhou J; Zhang N; Zuo Y; Xu F; Cheng L; Fu Y; Yang F; Shu M; Zhou M; Zou W; Zhang S
    Hereditas; 2024 Sep; 161(1):35. PubMed ID: 39300580
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Myeloproliferative neoplasms: young patients, current data and future considerations.
    Sobas M; Ianotto JC; Kiladjian JJ; Harrison C
    Ann Hematol; 2024 Sep; 103(9):3287-3291. PubMed ID: 39110200
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comprehensive characterization of immunogenic cell death in acute myeloid leukemia revealing the association with prognosis and tumor immune microenvironment.
    Chen Y; Qiu X; Liu R
    BMC Med Genomics; 2024 Apr; 17(1):107. PubMed ID: 38671491
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.
    Ferrer-Marín F; Hernández-Boluda JC; Alvarez-Larrán A
    Br J Haematol; 2024 May; 204(5):1605-1616. PubMed ID: 38586911
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Triple-Negative Myelofibrosis: Disease Features, Response to Treatment and Outcomes.
    Aguirre LE; Jain A; Ball S; Ali NA; Volpe VO; Tinsley-Vance S; Sallman D; Sweet K; Lancet J; Padron E; Yun S; Kuykendall A; Komrokji R
    Clin Lymphoma Myeloma Leuk; 2024 Jul; 24(7):459-467. PubMed ID: 38548563
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Clinical and prognostic characteristics of pediatric acute myeloid leukemia with myelodysplasia-related changes under different diagnostic criteria].
    Zhang RR; Ruan M; Liu TF; Wang SC; Zhang XY; Qi BQ; Zhu XF; Zhang L
    Zhonghua Er Ke Za Zhi; 2024 Mar; 62(3):250-255. PubMed ID: 38378287
    [No Abstract]    [Full Text] [Related]  

  • 7. Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management.
    Tefferi A; Vannucchi AM; Barbui T
    Am J Hematol; 2024 Apr; 99(4):697-718. PubMed ID: 38269572
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. STAT5a and SH2B3 novel mutations display malignancy roles in a triple-negative primary myelofibrosis patient.
    Zhang S; Yan J; He L; Jiang Z; Jiang H
    Cancer Gene Ther; 2024 Mar; 31(3):484-494. PubMed ID: 38135698
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Clinical characteristics and prognosis of patients with therapy-related myelodysplastic syndrome and acute myeloid leukemia arising from malignant tumors].
    Xu XS; Ding H; Zhang X; Liao Y; Li H; Liu QY; Liu JZ; Zhang L; Huang J; Gong YP; Ma HB; Xiang B; Dai Y; Hou L; Shuai X; Niu T; Wu Y
    Zhonghua Xue Ye Xue Za Zhi; 2023 Sep; 44(9):742-748. PubMed ID: 38049318
    [No Abstract]    [Full Text] [Related]  

  • 10. [Clonal hematopoiesis and its evolution of myeloproliferative neoplasms].
    Zhang L; Dong H
    Zhonghua Yi Xue Za Zhi; 2023 Dec; 103(45):3608-3614. PubMed ID: 38018059
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Enhancing information on stage at diagnosis for childhood cancer in Africa.
    Liu B; Abraham N; Chitsike I; Sylvie CGL; Kambugu J; Stévy NMA; Pondy AHO; Renner L; Parkin DM
    Pediatr Blood Cancer; 2023 Oct; 70(10):e30555. PubMed ID: 37432023
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Cytological Diagnosis of Classic Myeloproliferative Neoplasms at the Age of Molecular Biology.
    Combaluzier S; Quessada J; Abbou N; Arcani R; Tichadou A; Gabert J; Costello R; Loosveld M; Venton G; Berda-Haddad Y
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980287
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Novel Molecular Insights into Leukemic Evolution of Myeloproliferative Neoplasms: A Single Cell Perspective.
    Rontauroli S; Carretta C; Parenti S; Bertesi M; Manfredini R
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499582
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Molecular prognostication in Ph-negative MPNs in 2022.
    Vannucchi AM; Guglielmelli P
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):225-234. PubMed ID: 36485130
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinicopathologic spectrum of myeloid neoplasms with concurrent myeloproliferative neoplasm driver mutations and SRSF2 mutations.
    Tashakori M; Khoury JD; Routbort MJ; Patel KP; Wang SA; Ok CY; El-Hussein S; Kanagal-Shamanna R; Luthra R; Hu S; Lin P; Pemmaraju N; Bose P; Verstovsek S; Bueso-Ramos CE; Medeiros LJ; Loghavi S
    Mod Pathol; 2022 Nov; 35(11):1677-1683. PubMed ID: 35690645
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Establishment and Validation of Immune Risk Score for Predicting Survival of Patients with Acute Myeloid leukemia].
    Hu F; Wang Y; Zhang Y; Zeng Y; Wang SQ; Pan XY; Yang TH; Liu QF; Liang Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):327-333. PubMed ID: 35395958
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Mutational landscape of blast phase myeloproliferative neoplasms (MPN-BP) and antecedent MPN.
    Pasca S; Chifotides HT; Verstovsek S; Bose P
    Int Rev Cell Mol Biol; 2022; 366():83-124. PubMed ID: 35153007
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Lab tests for MPN.
    Moncada A; Pancrazzi A
    Int Rev Cell Mol Biol; 2022; 366():187-220. PubMed ID: 35153004
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Myeloproliferative Neoplasms with Monocytosis.
    Morsia E; Gangat N
    Curr Hematol Malig Rep; 2022 Feb; 17(1):46-51. PubMed ID: 34773576
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clinical characteristics, prognostic factors, and outcomes of patients with essential thrombocythemia in Japan: the JSH-MPN-R18 study.
    Hashimoto Y; Ito T; Gotoh A; Nakamae M; Kimura F; Koike M; Kirito K; Wada H; Usuki K; Tanaka T; Mori T; Wakita S; Saito TI; Kada A; Saito AM; Shimoda K; Sugimoto Y; Kurokawa T; Tomita A; Edahiro Y; Akashi K; Matsumura I; Takenaka K; Komatsu N
    Int J Hematol; 2022 Feb; 115(2):208-221. PubMed ID: 34727329
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.